ChromaDex Changing Name To Niagen Bioscience While Shifting Focus To Rx NAD+

 
• By Malcolm Spicer
  
ChromaDex rolled out Rx nicotinamide adenine dinucleotide products in August, along with a test kit for providers and consumers. (Source: CHromaDex)

More from Strategy

More from HBW Insight